HSIC - Henry Schein Inc Stock Analysis
Henry Schein Inc (HSIC) is a publicly traded company listed on the Mid. It operates in the Medical Distribution industry, part of the broader Healthcare sector. The company has a market capitalization of 9.26B, generates annual revenue of 13.38B, and reports net income of 395.00M. As of the latest data, the stock is trading at 81.25 USD.
From a valuation and risk perspective, the stock presents the following profile: The stock is moderately valued and aligns with market expectations for established companies. The PEG ratio is within a normal range, suggesting the stock is fairly priced for its expected growth. The company uses a significant amount of debt to finance its operations, which can boost returns but adds financial risk. This stock does not currently pay a dividend. The stock has average market volatility, aligning with general market movement.
Analyst recommendation stands at Hold (3.79), indicating current market sentiment. Institutional ownership is reported at 94.16%, reflecting confidence from large investors. Over the last 12 months, the stock has shown a performance of 14.31%, trading within a 52-week range of 61.94 - 89.29.
HSIC - Henry Schein Inc
81.25
Analyst Consensus
Hold 3.79
HSIC – Analyst Rating Summary
- Strong Buy: 6
- Buy: 8
- Hold: 9
- Sell: 1
- Strong Sell: 0
- Total Analysts: 24
| Index: | S&P 500 | P/E: | 24.54 | EPS (ttm): | 3.31 | Insider Own: | 15.22% | Shs Outstand: | 114.42M | Perf Week: | 4.91% |
| Market Cap: | 9.26B | Forward P/E: | 13.75 | EPS next Y: | 5.91 | Insider Trans: | -0.55% | Shs Float: | 96.58M | Perf Month: | 16.99% |
| Income(ttm): | 395.00M | PEG: | 1.47 | EPS next Q: | 1.24 | Inst Own: | 94.16% | Short Float: | 8.44% | Perf Quarter: | 7.52% |
| Revenue(ttm): | 13.38B | P/S: | 0.69 | EPS this Y: | 7.57% | Inst Trans: | -0.04% | Short Ratio: | 5.87 | Perf Half Y: | 7.08% |
| Book/sh: | 28.54 | P/B: | 2.85 | EPS next Y: | 10.50% | ROA: | 3.63% | Short Interest: | 8.15M | Perf Year: | 14.31% |
| Cash/sh: | 1.21 | P/C: | 67.07 | EPS next 5Y: | 9.34% | ROE: | 12.01% | 52W Range: | 61.94 - 89.29 | Perf YTD: | 7.50% |
| Dividend Est.: | - | P/FCF: | 20.80 | EPS past 3/5Y: | -5.75% 3.12% | ROIC: | 6.75% | 52W High: | 89.29 -9.00% | Beta: | 0.80 |
| Dividend TTM: | - | Quick Ratio: | 0.75 | Sales past 3/5Y: | 1.40% 5.43% | Gross Margin: | 29.19% | 52W Low: | 61.94 31.16% | Perf 5Y: | 2.98% |
| Dividend Ex-Date: | - | Current Ratio: | 1.36 | EPS Y/Y TTM: | 2.92% | Oper. Margin: | 5.88% | RSI (14): | 71.22 | Volatility: | 2.66% 2.46% |
| Employees: | 25000 | Debt/Eq: | 1.15 | Sales Y/Y TTM: | 5.64% | Profit Margin: | 2.95% | Recom: | 2.26 | Target Price: | 87.21 |
| Option/Short: | Yes / Yes | LT Debt/Eq: | 0.79 | EPS Q/Q: | 4.63% | Payout: | 0.00% | Rel Volume: | 0.78 | Prev Close: | 80.22 |
| Sales Surprise: | 0.77% | EPS Surprise: | 8.38% | Sales Q/Q: | 6.31% | Earnings: | May 05 BMO | Avg Volume: | 1.39M | Price: | 81.25 |
| SMA20: | 6.76% | SMA50: | 7.88% | SMA200: | 10.65% | Undervalued: 7.34% | Volume: | 1,089,044 | Change: | 1.28% | |
Graham Classic formula value: 80.79
(P/E=8 * 1g) Min value: 51.54
(current P/E * 2g) Max value: 128.46
Average value: 86.93
About Henry Schein Inc
Henry Schein, Inc. engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. It operates through the following segments: Global Distribution and Value-Added Services, Global Specialty Products, and Global Technology. The Global Distribution and Value-Added Services segment focuses on distribution to the global dental and medical markets of national brand and corporate brand merchandise, and equipment and related technical services. The Global Specialty Products segment includes manufacturing, marketing and sales of dental implant and biomaterial products, endodontic, orthodontic and orthopedic products. The Global Technology segment focuses on development and distribution of practice management software, e-services, and other products, which are distributed to health care providers. The company was founded by Henry Schein and Esther Schein in 1932 and is headquartered in Melville, NY.
Attention! Trading on the stock market involves financial risks and is not suitable for everyone. The www.stocks-expert.com does not provide financial market trading services; it is for informational purposes only and is not responsible for the consequences of your trading decisions or the operation of the software. Before starting to trade in any markets, make sure you understand the risks associated with trading and that you have a sufficient level of training.